Qi Zhao - Publications

Self-Assembled Multiepitope Nanovaccine Provides Long-Lasting Cross-Protection against Influenza Virus.

Journal: Advanced healthcare materials

Published: October 16, 2023

Deep-learning-based survival prediction of patients with cutaneous malignant melanoma.

Journal: Frontiers in medicine

Published: February 14, 2023

ERC-BiP Functional Protein Pathway for Assessing Endoplasmic Reticulum Stress Induced by SARS-CoV-2 Replication after Cell Invasion.

Journal: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Published: December 27, 2022

Association between multiple meteorological variables and seasonal influenza A and B virus transmission in Macau.

Journal: Heliyon

Published: March 28, 2022

2022 update on the scientific premise and clinical trials for IL-15 agonists as cancer immunotherapy.

Journal: Journal of leukocyte biology

Published: January 17, 2022

The Trend of Immunotherapy Combined with Nanomedicine.

Journal: Current medicinal chemistry

Published: June 28, 2021

Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer.

Journal: Frontiers in pharmacology

Published: June 17, 2020

Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing.

Journal: Frontiers in immunology

Published: October 16, 2018

Effects of insulin on transcriptional response and permeability in an in vitro model of human blood-brain barrier.

Journal: Journal of cellular biochemistry

Published: August 24, 2017

Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy.

Journal: Advanced healthcare materials

Published: December 08, 2015